J&J's 6% slide on an imperfect quarter is a gift to prospective buyers
CNBC 财报 · 2026-10-14 01:44 · 资讯
J&J's pharmaceutical division is humming along, and the MedTech problems should be temporary.
J&J's pharmaceutical division is humming along, and the MedTech problems should be temporary.
话题:#J&J's 6% slide on an imperfect quarter
墨子AI